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Introduction: Known causes of granulomatous inflammation must be excluded before the diag-
nosis of sarcoidosis can be secured. We explored the possibility that connective tissue diseases
(CTDs) could be a cause of granulomatous inflammation through an analysis of patients cared
for in 2 medical centers and a review of the medical literature.
Methods: Patients with both a diagnosis of sarcoidosis and a CTD were identified at two med-
ical centers. In addition, a literature search identified reported cases of patients with both di-
agnoses.
Results: We identified 15 patients at 2 medical centers plus 53 previous reported patients in
the medical literature (totalZ 68) with diagnoses of both sarcoidosis and a CTD. The patients
were predominantly female. Scleroderma was the most common CTD. Only 2/59 (3%) with
chest radiographs recorded had fibrocystic (stage 4) disease. In 48/67 (72%) patients where
the time of diagnosis was recorded, sarcoidosis was diagnosed simultaneously or after the
CTD. Sarcoidosis in only one organ ("isolated sarcoidosis") was associated with sarcoidosis being
diagnosed simultaneously or after the CTD (pZ 0.0001).
Conclusions: These data suggest that a significant portion of patients with CTDs and sarcoidosis262 5196.
c.edu (M.A. Judson).
3 Elsevier Ltd. All rights reserved.
3.01.004
1454 M.A. Judson et al.may actually not have the latter disease. Rather, the CTD may "cause" granulomatous inflam-
mation. Alternate explanations for these findings include that sarcoidosis and/or the connec-
tive tissue disease was misdiagnosed in these patients. The diagnosis of a concomitant
connective tissue disease and sarcoidosis must be made with extreme caution.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Sarcoidosis is a multisystem granulomatous disease of un-
known etiology.1 To that end, all alternative granulomatous
diseases need to be excluded before the diagnosis of sar-
coidosis can be secured.2,3 These diseases include infections
frommycobacteria and fungi,1 occupational diseases such as
chronic beryllium disease,4 and lymphoma.1
Connective tissue diseases are not generally recognized
as being a cause of granuloma formation. However, many
case reports and very small case series have suggested that
there is an association between connective tissue diseases
and sarcoidosis. Although no epidemiological analysis of
such an association has been undertaken, it is extremely
unlikely that a patient would develop both diseases con-
comitantly given their prevalence. We undertook a retro-
spective analysis of patients with concomitant sarcoidosis
and a connective tissue disease at two medical university
centers. It is important to emphasize that we did not per-
form an epidemiological analysis of the association be-
tween sarcoidosis and connective tissue diseases. Rather,
we aimed to characterize the clinical presentation and
characteristics of patients with a history of both diseases.
In addition, we reviewed the medical literature to identify
and describe patients who were previously reported to have
both conditions.
Methods
This study was conducted at the Medical University of South
Carolina (MUSC) and Albany Medical College (AMC). It was
approved by the Institutional Review Boards at both in-
stitutions. At MUSC, ICD-9 codeswere examined and patients
were identified who were coded as having sarcoidosis as well
as one of the following diseases: systemic lupus erythema-
tosus, systemic sclerosis, Sjo¨gren’s syndrome, dermatomy-
ositis, polymyositis, psoriatic arthritis, rheumatoid arthritis,
and undifferentiated connective tissue disease. At AMC,
patients were identified using established sarcoidosis and
rheumatology clinical databases. At both AMC and MUSC,
patients were identified over a 10-year period of time.
The patients identified by ICD-9 coding were considered
to have a history of sarcoidosis if, upon medical chart re-
view: (1) there was documented tissue confirmation of
noncaseating granulomas on biopsy of one or more organs;
(2) alternative causes of granulomatous inflammation were
reasonably excluded1; and (3) the presence of clinical signs
or symptoms consistent with sarcoidosis were present.2
Only such patients could be entered into the AMC and
MUSC sarcoidosis databases. Involvement of an organ with
sarcoidosis was determined by using the ACCESS organ
assessment instrument.5The patients identified by ICD-9 coding were considered
to have a history of a connective tissue disease if, upon
medical chart review, they fulfilled standard criteria for
these diagnosis.6e21
Only patients fulfilling the above criteria for both a his-
tory of sarcoidosis and a connective tissue disease were
included in this analysis. Patients were not required to have
these two diseases concurrently. Data were collected ret-
rospectively and included: age, race, year of diagnosis of
sarcoidosis, year of connective tissue disease diagnosis,
biopsy data, radiographic findings, and pulmonary function
testing. The diagnosis of sarcoidosis and a connective tissue
disease were classified as “simultaneous” if they were the
diagnoses related to symptoms and/or clinical findings that
occurred concurrently. Scadding stages22 of sarcoidosis
were determined by reports of chest radiographs or chest
computed tomography scans. Sarcoidosis organ involvement
was determined on the basis of the A Case Control Etiology
of Sarcoidosis Study (ACCESS) organ assessment system.5
Patients with concomitant sarcoidosis and a connective
tissue disease who had been described in the medical liter-
ature were identified via Medline and PubMed database
searches through October 1 2012 using the following terms,
sarcoidosis, rheumatoid arthritis, scleroderma, systemic
sclerosis, lupus, systemic lupus erythematosus, dermatomy-
ositis, polymyositis, Behcet’s syndrome, mixed connective
tissuedisease, overlap syndrome,Wegener’s granulomatosis,
granulomatosis with polyangiitis, microscopic polyangiitis,
psoriatic arthritis, Reiter’s syndrome, reactive arthritis. All
manuscripts identified by this method were evaluated to
determine if the reported clinical data supported con-
comitant diagnoses of sarcoidosis and a connective tissue
disease.Results
We identified 15 patients (8 at MUSC, 7 at AMC) with con-
comitant sarcoidosis and a connective tissue disease
(Table 1). The patients were all female. Systemic lupus
erythematosus (4/15, 27%), scleroderma (4/15, 27%),
rheumatoid arthritis (3/15, 20%) accounted for the con-
nective tissues diseases found in 11 of the 15 patients
(73%).
Table 2 shows the clinical features of sarcoidosis in our
cohort. The lung was the most common organ involved,
followed by the skin, peripheral lymph node, eye, and liver.
The most common Scadding stage at the time of sarcoidosis
presentation was stage 1 (bilateral hilar adenopathy with-
out parenchymal infiltrates). Only 1/15 (7%) patients had
stage 4 (fibrocystic) disease. Four patients in our cohort had
evidence of only one organ involvement with sarcoidosis:
mediastinal lymph node (3 patients), peripheral lymph
Table 1 Clinical characteristics of the cohort (nZ 15).
Age at sarcoidosis diagnosis (mean years SD)
Gender, N (%)
Male 0, 0%
Female 15, 100%
Race, N (%)
Black 7, 47%
White 8, 53%
Connective tissue disease, N (%)
Psoriatic arthritis 2, 13%
Systemic lupus erythematosis 4, 27%
Rheumatoid arthritis 3, 20%
Myositis (dematomyositis/polymyositis) 2, 13%
Scleroderma 4, 27%
Concomitant sarcoidosis and a connective tissue disease 1455node (1 patient). In 3 of these 4 patients, sarcoidosis was
diagnosed simultaneously or after the diagnosis of a con-
nective tissue disease was made (these data not shown).
The connective tissue diseases were all confirmed by
established clinical criteria (see methods section).
Sarcoidosis presented prior to the connective tissue
disease in 8 of 15 patients (53%). A connective tissueTable 2 Clinical features of sarcoidosis in the cohort
(nZ 15).
Organ Definite or
probable organ
involvementb N (%)
Biopsy showing
noncaseating
granulomas N (%)
A. Specific organ involvement
Lunga 13, 87% 9, 60%
Skin 5, 33% 3, 20%
Eye 3, 20% 0, 0 %
Liver 2, 13% 2, 13%
Peripheral
lymph node
4,27% 4, 27%
Calcium
dysregulation
2, 13% 0, 0%
SURT 1, 7% 0, 0%
Parotid 1, 7% 0, 0%
B. Number of organs involvedb per patient
1 4, 27% 12, 80%
2 7, 47% 3,20%
3 4, 27% 0, 0%
> 3 0, 0% 0, 0%
C. Chest radiograph/Chest CT Scadding stage
N (%)
0 1, 7%
1 8, 53%
2 4, 27%
3 0, 0%
4 1, 7%
Unknown 1, 7%
a Includes mediastinal lymph nodes.
b Judson et al.5disease presented prior to sarcoidosis in 3 of 15 patients
(20%). Both diseases presented concomitantly in 2 patients
(13%).
In our literature review, we identified 53 patients who
had been previously reported to have sarcoidosis and
a connective tissue disease.23e55 Table 3 shows the clinical
characteristics of these patients. There were missing data
concerning several of these 53 patients. Similar to our
cohort, these patients were predominantly female. Also
similar to our cohort, only 1 of 45 (2%) had stage 4 disease
(some radiographic data were not reported). Scleroderma
was the most common connective tissue disease identified
in these patients (24/52, 46%). Similar to our cohort, sys-
temic lupus erythematosus (10/52, 19%) and rheumatoid
arthritis (9/52, 17%) were the next two most common
connective tissue diseases reported. In contrast to our
cohort, only 10/52 (19%) of the previous patients reported
were first diagnosed with sarcoidosis prior to the diagnosis
of a connective tissue disease.
Fig. 1 shows the time (in years) between the diagnosis of
sarcoidosis and the connective tissue disease in each indi-
vidual patient in both our cohort and the patients previ-
ously reported in the literature. The diagnosis of the
connective tissue disease preceded that of sarcoidosis in
31/67 (46%), concomitantly (simultaneously or within a few
months) in 17/67 (25%), and sarcoidosis preceded the
diagnosis of the connective tissue disease in 19/67 (28%).
Data concerning the time between the two diagnoses were
not available for one patient.
In 16 of the 53 cases (30%) identified in the literature,
only one organ was clinically involved with sarcoidosis: lung
(10),27,30,32,44,50e52 skin (3),29,34,49 mediastinal lymph node
(1),34 muscle (1).42 Although Table 3 lists 21 patients who
had only one organ involved with sarcoidosis, we assumed
that 5 of these patients had evidence of multisystem sar-
coidosis (erythema nodousum present in two,26,34 one had
a Kveim test that was positive,26 one had a lung and
mediastinal lymph node biopsy both showing granulomatous
inflammation,40 one had a lung biopsy with hilar adenop-
athy47). In 15 of these 16 cases, sarcoidosis was diagnosed
simultaneously or after the diagnosis of a connective tissue
disease was made. We combined data from our cohort with
the literature data to examine if “isolated sarcoidosis”
(clinical sarcoidosis in only one organ) was associated with
the diagnosis of a connective tissue disease preceding the
diagnosis of sarcoidosis. We found a highly statistically
significant association (Fig. 2).Discussion
We describe 15 patients at two institutions who were
diagnosed with sarcoidosis as well as a connective tissue
disease over a 10-year period. The diagnosis of both con-
ditions was well-documented in most cases with multi-
system granulomatous inflammation of unknown cause
established in most cases of sarcoidosis and adequate
clinical data to support a diagnosis of a connective tissue
disease. Sarcoidosis organ involvement was similar to pre-
vious series with the lung being most commonly involved
and the skin, liver, eye, and peripheral lymph node being
other frequently involved organs.56,57
Table 3
Manuscript No. of patients with the characteristic
N Sex Race Connective tissue disease(s) No. of organ(s)
involved
No. of organ(s)
biopsied
Radiographic
stagea
M F W B A Scl MCTD MYO SLE RA PA 1 2 3 4 5 0 1 2 3 4 0 1 2 3 4
Arapis 1 1 1 1 1 1
Aronson 1 1 1 1 1 1
Asanuma 1 1 1 1 1 1 1
Begum 3 3 2 1 1 1 1 2 1 1 2 2 1
Biasi 1 1 1 1 1 1
Brateauu 1 1 1 1 1 1 1
Callen 1 1 1 1 1 1
Cox 7 3 4 6 1 7 4 2 1 7 6 1
Davis 1 1 1 1 1 1 1
DeBandt 5 1 4 2 1 2 5 1 3 1 2 2 1
Dong 1 1 1 1 1 1 1
Enzenauer 4 4 3 1 2 1 1 3 1 4 1 1 2
Fallahi 2 2 1 1 2 1 1 1 1 1
Groen 1 1 1 1 1 1
Harrison 1 1 1 1 1 1
Hillerdal 1 1 1 1 1 1
Hosoya 1 1 1 1 1 1 1
Hunter 1 1 1 1 1 1 1
Ito 1 1 1 1 1 1 1
Itoh 1 1 1 1 1 1 1
Kubis 1 1 1 1 1 1 1
Kucera 2 2 2 2 2 2 1 1
Lipton 1 1 1 1 1 1
Maekawa 1 1 1 1 1 1 1
Menard 1 1 1 1 1 1 1
Needleman 1 1 1 1 1 1 1
Putkonen 1 1 1 1 1
Schnabel 1 1 1 1 1 1
Sharma2 1 1 1 1 1 1
Takahashi 1 1 1 1 1 1
Thompson 1 1 1 1 1 1 1
Umeki 1 1 1 1 1 1
Wiesenhutter 4 2 2 2 2 3 1 4 2 2 1 2 1
Total from literature 53 10 43 21 12 8 25 2 7 9 10 21 24 4 3 1 1 40 10 1 1 4 10 20 10 1
Our cohort 15 0 15 8 7 4 2 4 3 2 4 7 4 12 3 1 8 4 0 1
Total 68 10 58 29 19 8 29 2 9 13 13 2 25 31 8 3 1 1 52 13 1 1 5 18 24 10 2
M: male; F: female; W: white; B: black; A: asian; Scl: scleroderma; MCTD: mixed connective tissue disease; MYO: dermatomyositis or
polymyositis; SLE: systemic lupus erythematosis; RA; rheumatoid arthritis; and PA: psoriatic arthritis.
a Scadding stage.
1456 M.A. Judson et al.We believe that these data could be interpreted in
several ways. First, our data could be interpreted as, in
a significant proportion of cases, the granulomatous
inflammation of “sarcoidosis” may have been the result of
the connective tissue disease. First, only 2 of the 59 (3%)
cases in which radiographic data was reported did the pa-
tients develop stage 4 fibrocystic sarcoidosis. This suggests
that “longstanding sarcoidosis” was not very common in
these patients. Secondly, the diagnosis of sarcoidosis ide-
ally requires evidence of multisystem disease. In 20/67
(31%) of patients where granulomatous inflammation was
found in only one organ, there was a strong statistical
relationship between this finding and sarcoidosis beingdiagnosed after the connective tissue disease. This suggests
that such patients did not, in fact, have systemic sarcoi-
dosis but possibly a local granulomatous reaction in
response to a connective tissue disease.
An alternative interpretation of these data is that, in
some of these cases, the patients did not, in fact, have
sarcoidosis. Sarcoidosis is defined as a multisystem gran-
ulomatous disease of unknown etiology.1 This definition
implies that granulomatous inflammation must be present
in at least two organs for the diagnosis to be secure. In
several of our patients and those in the literature, gran-
ulomatous inflammation was only identified in one organ.
Therefore, the diagnosis of sarcoidosis could be considered
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Fig. 1 Bar graph of each individual patient in our cohort and the literature in terms the number of years that the diagnosis of
sarcoidosis was made prior to the diagnosis of a connective tissue disease. The negative values imply that the connective tissue
disease was made prior to the diagnosis of sarcoidosis. In those patients with a “0,” the diagnosis of sarcoidosis and the connective
tissue disease were made simultaneous (see text for definition of simultaneous diagnosis). One of the 68 patients did not have data
to make a determination of the time between diagnoses.
Concomitant sarcoidosis and a connective tissue disease 1457premature in these patients. However, even if this inter-
pretation explains the situation for some of the patients in
this report, the majority of them had evidence of gran-
ulomatous inflammation in more than one organ.
A final interpretation of these data is that the diagnosis
of the connective tissue disease was not secure. We believe
that we followed rigorous criteria in establishing these di-
agnoses. Nevertheless, given the systemic effects of
both diseases, we must acknowledge that clinical mani-
festations that we or previous authors attributed to a con-
nective tissue disease could possibly have been related to
sarcoidosis.
Although this was not an epidemiologic study, the
number of cases identified seems greater than what would
be expected by chance alone. We found this to be partic-
ularly the case with respect to scleroderma where the
overall incidence rate of scleroderma in the population of
the United States is approximately 24 per 100,000.58 The
prevalence of sarcoidosis in the United States is estimated
at 15 per 100,000.59 Therefore, if developing scleroderma
and sarcoidosis were independent events, the prevalence
of concomitantly having both diseases in the United States
would be approximately 3.6/100,000,000. That would sug-
gest that there should be 12 such cases in the United States.
Therefore, if these diseases were not related, it would
appear to be statistically unlikely that we would identify 4
such patients in two medical centers. These results suggestFig. 2 Two by 2 Fisher exact test results.that these diseases are not independent from each other
and have some genetic, immunologic, and/or environ-
mental association.
There are a number of limitations of this study. This was
a retrospective analysis so that there was not a uniform
approach to the diagnosis and assessment of sarcoidosis and
connective tissue diseases in our cohort. Therefore, there
was a great deal of missing data concerning serology, organ
involvement, and biopsy confirmation in this cohort. Deter-
mination of the time of diagnosis is problematic. The diag-
nosis of sarcoidosis is often delayed because (a) the
symptoms of sarcoidosis are not specific, and it is often
misdiagnosed as alternative conditions60 and (b) sarcoidosis
often causes no symptoms so that it may only be diagnosed
by performing testing in an asymptomatic individual (e.g.,
pre-employment chest radiograph). Similarly, the diagnosis
of connective tissue diseases, especially scleroderma is
often made long after the onset of symptoms. (Ball, 2004
#1205) We had inadequate information concerning the
treatment of sarcoidosis and connective tissue diseases in
this cohort. Treatment decisions concerning one of these
two diseases may have affected the phenotypic expression
of the other disease. In addition, various treatments
may lead to manifestations of these diseases, such as
methotrexate-induced granulomatous disease61 and TNF-
antagonist-induced vasculitis.62,63 However, we did not
identify any such patients in our cohort. Patients were not
followed at regular intervals so that clinical course of these
diseases could not be determined in detail. Misclassification
of the Scadding stage of the chest radiograph may have
occurred because parenchymal infiltrates may have been
the result of connective tissue disease induced interstitial
lung disease. In terms of the literature review, there may
have been numerous publication biases that affected the
cases that were reported.
In summary, we report a large cohort of patients with
concomitant sarcoidosis and a connective tissue disease as
well as review the medical literature concerning this topic.
Sarcoidosis organ involvement was similar to previously
1458 M.A. Judson et al.reported large sarcoidosis series. Although this analysis is
exploratory, our data may suggest an association of sar-
coidosis with connective tissue diseases, especially scle-
roderma. Previous analyses have found statistically
significant familial associations between rheumatoid
arthritis and both sarcoidosis and other autoimmune dis-
eases.64 The highly discordant familial risks suggest that
there may be extensive genetic sharing between these
diseases.64 We believe that these data suggest the con-
comitant diagnoses of sarcoidosis and a connective tissue
disease should be made cautiously. This association may be
based on a mis-diagnosis of one of these two diseases, or
possibly, the connective tissue disease may cause gran-
ulomatous inflammation.Conflict of interest statement
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